Chemical shift magnetic resonance imaging could predict subclinical cortisol production from an incidentally discovered adrenal mass.

Yener S., SEÇİL M., Demir O., Saydam B. O., YÖRÜKOĞLU K.

Clinical endocrinology, cilt.88, sa.6, ss.779-786, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 88 Sayı: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1111/cen.13587
  • Dergi Adı: Clinical endocrinology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.779-786
  • Anahtar Kelimeler: Adrenal incidentaloma, Hypercortisolism, magnetic resonance imaging, CLINICAL-PRACTICE GUIDELINE, CUSHINGS-SYNDROME, ADRENOCORTICAL ADENOMAS, HYPERCORTISOLISM, MANAGEMENT, SOCIETY, MUTATION, PRKACA, TUMORS
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

ContextTo investigate whether any association between chemical shift magnetic resonance (MRI) findings, cortisol secretion and pathological findings exists that could predict subclinical hypercortisolism (SCH) in patients with adrenal incidentalomas (AI).